The Use of Preginor in the Treatment of Pregnancy-Associated Nausea and Vomiting

The article presents the results of the research aimed at estimating the effi cacy of ginger extract
preginor in pregnant women with nausea and vomiting. The study included 42 women with
pregnancy of 4–20 weeks, suff ering from mild to moderate nausea and vomiting. preginor was
prescribed for 1 capsule (equivalent to 1000 mg of dry powder of ginger root) with meals 2 times a
day for 10 days. Severity of vomiting was assessed by Rhodes Index of Nausea and Vomiting. Results.
A general urine test for acetone was carried out to assessing intensity and severity of pregnancyassociated
nausea and vomiting. The effi cacy of preginor for pregnancy-associated nausea
and vomiting was evaluated on the 10th day of treatment and compared with the initial values
(p<0.05). Only one or two vomiting a day persisted in 5 (11.9%) pregnant women by the end of treatment. The effi cacy of the treatment was noted to all symptoms: decreasing appetite was noted by 8 (19%) women (76.2% before treatment), weakness persisted in 8 (19%) women (71.4% before treatment), dizziness was noted by 6 (14.3%) women (42.8% before treatment). Changing in taste and olfactory sensations after treatment was noted by 3 (7.14%) patients (14.3% before treatment), 2 (4.8%) women (38.1% before treatment) complained of salivation, constipation persisted in 3 (7.14%) women (19% before treatment). Almost all patients stopped losing weight, while most of them showed a tendency to increase it. Only 4 (9.5%) pregnant women had a weakly positive urine reaction to acetone by the end of treatment (52.4% of pregnant women had a positive and weak positive reaction before treatment). no side eff ects were registered with the use of preginor. The results confi rm the literature data on the effi cacy of ginger in the treatment of pregnancy-associated nausea and vomiting.